Skip to main content

Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

Volume 6, Number 4, December 2010


Discovery of Dual Chemotherapy Drug Candidates Designed by Molecular Hybridization
pp. 171-182(12)
Authors: do Couto Maia, Rodolfo; Alberto Manssour Fraga, Carlos


Peptidase Inhibitors as a Possible Therapeutic Strategy for Chagas Disease
pp. 183-194(12)
Authors: Capaci Rodrigues, Giseli; Palermo Aguiar, Alcino; Lidio da Silva Goncalves Vianez, Joao; Macrae, Andrew; Cristina Nogueira de Melo, Ana; Beatriz Vermelho, Alane


Targets for Anti-T. cruzi Drugs in the Post-Genomic Era
pp. 195-210(16)
Authors: Merlino, Alicia; Gonzalez, Mercedes; Cerecetto, Hugo


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more